AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $861,257 | +42.2% | 755,488 | +14.1% | 0.00% | 0.0% |
| Q2 2023 | $605,637 | +319.3% | 661,898 | +156.8% | 0.00% | – |
| Q1 2023 | $144,440 | +1162.9% | 257,744 | +1200.3% | 0.00% | – |
| Q4 2022 | $11,437 | +90.6% | 19,822 | -0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -25.0% | 19,830 | -17.3% | 0.00% | – |
| Q2 2022 | $8,000 | -20.0% | 23,978 | +4.2% | 0.00% | – |
| Q1 2022 | $10,000 | -81.1% | 23,013 | -2.8% | 0.00% | – |
| Q4 2021 | $53,000 | -24.3% | 23,670 | -2.8% | 0.00% | – |
| Q3 2021 | $70,000 | -21.3% | 24,347 | +3.8% | 0.00% | – |
| Q2 2021 | $89,000 | +14.1% | 23,464 | +1.2% | 0.00% | – |
| Q1 2021 | $78,000 | +23.8% | 23,188 | +3.0% | 0.00% | – |
| Q4 2020 | $63,000 | +18.9% | 22,519 | +6.3% | 0.00% | – |
| Q3 2020 | $53,000 | -82.5% | 21,189 | -5.1% | 0.00% | – |
| Q2 2020 | $303,000 | +5.2% | 22,327 | -41.1% | 0.00% | – |
| Q1 2020 | $288,000 | +51.6% | 37,912 | +25.9% | 0.00% | – |
| Q4 2019 | $190,000 | +143.6% | 30,111 | +50.9% | 0.00% | – |
| Q3 2019 | $78,000 | – | 19,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |